Neuroprotective effect of the 3α5β-pregnanolone glutamate treatment in the model of focal cerebral ischemia in immature rats

Neuroscience Letters

Volumn 564, Issue , 2014, Pages 11-15

  Kleteckova, Lenka ^a,b,c   Tsenov, Grygoriy ^a   Kubova, Hana ^a   Stuchlik, Ales ^a   Vales, Karel ^a  

^a INSTITUTE OF MATHEMATICS   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c NONE   (Czech Republic)

Author keywords

3 5 Pregnanolone glutamate; Endothelin 1; Focal cerebral ischemia; Immature rats; NMDA receptors

Indexed keywords

20-OXO-5-PREGNAN-3-YL-GLUTAMYL 1-ESTER; ELTANOLONE; GLUTAMIC ACID DERIVATIVE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT;

ANALOGS AND DERIVATIVES; ANIMAL; ANTAGONISTS AND INHIBITORS; BRAIN ISCHEMIA; DISEASE MODEL; DRUG EFFECTS; HIPPOCAMPUS; MALE; PATHOLOGY; RAT; TOXICITY; WISTAR RAT;

ANIMALS; BRAIN ISCHEMIA; DISEASE MODELS, ANIMAL; GLUTAMATES; HIPPOCAMPUS; MALE; NEUROPROTECTIVE AGENTS; PREGNANOLONE; RATS; RATS, WISTAR; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 84894485267     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.01.057     Document Type: Article

References (37)

1. Ben-Ari Y. Effects of anoxia and aglycemia on the adult and immature hippocampus. Biology of the Neonate 1992, 62:225-230.
2. Chen H.S., Pellegrini J.W., Aggarwal S.K., Lei S.Z., Warach S., Jensen F.E., Lipton S.A. Open-channel block of N-methyl-d-aspartate (NMDA) responses by memantine: therapeutic advantage against NMDA receptor-mediated neurotoxicity. Journal of Neuroscience: Official Journal of the Society for Neuroscience 1992, 12:4427-4436.
3. Del Bigio M.R., Becker L.E. Microglial aggregation in the dentate gyrus: a marker of mild hypoxic-ischaemic brain insult in human infants. Neuropathology and Applied Neurobiology 1994, 20:144-151.
4. Deshpande S.S., Smith C.D., Filbert M.G. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Archives of Toxicology 1995, 69:384-390.
5. Dingledine R., Borges K., Bowie D., Traynelis S.F. The glutamate receptor ion channels. Pharmacological Reviews 1999, 51:7-61.
6. Druga R., Mares P., Otahal J., Kubova H. Degenerative neuronal changes in the rat thalamus induced by status epilepticus at different developmental stages. Epilepsy Research 2005, 63:43-65.
7. Fuxe K., Bjelke B., Andbjer B., Grahn H., Rimondini R., Agnati L.F. Endothelin-1 induced lesions of the frontoparietal cortex of the rat. A possible model of focal cortical ischemia. NeuroReport 1997, 8:2623-2629.
8. Gilmour G., Iversen S.D., O'Neill M.F., Bannerman D.M. The effects of intracortical endothelin-1 injections on skilled forelimb use: implications for modelling recovery of function after stroke. Behavioural Brain Research 2004, 150:171-183.
9. Giroud M., Lemesle M., Gouyon J.B., Nivelon J.L., Milan C., Dumas R. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. Journal of Clinical Epidemiology 1995, 48:1343-1348.
10. Grivas I., Michaloudi H., Batzios C., Chiotelli M., Papatheodoropoulos C., Kostopoulos G., Papadopoulos G.C. Vascular network of the rat hippocampus is not homogeneous along the septotemporal axis. Brain Research 2003, 971:245-249.
11. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 1999, 283:70-74.
12. Johnston M.V. Excitotoxicity in perinatal brain injury. Brain Pathology 2005, 15:234-240.
13. Kocaeli H., Korfali E., Ozturk H., Kahveci N., Yilmazlar S. MK-801 improves neurological and histological outcomes after spinal cord ischemia induced by transient aortic cross-clipping in rats. Surgical Neurology 2005, 64(Suppl 2):S22-S26. discussion S27.
14. Korinek M., Kapras V., Vyklicky V., Adamusova E., Borovska J., Vales K., Stuchlik A., Horak M., Chodounska H., Vyklicky L. Neurosteroid modulation of N-methyl-d-aspartate receptors: molecular mechanism and behavioral effects. Steroids 2011, 76:1409-1418.
15. Lapchak P.A. 3alpha-OL-5-beta-pregnan-20-one hemisuccinate, a steroidal low-affinity NMDA receptor antagonist improves clinical rating scores in a rabbit multiple infarct ischemia model: synergism with tissue plasminogen activator. Experimental Neurology 2006, 197:531-537.
16. Lapchak P.A. Memantine, an uncompetitive low affinity NMDA open-channel antagonist improves clinical rating scores in a multiple infarct embolic stroke model in rabbits. Brain Research 2006, 1088:141-147.
17. Lapchak P.A. The neuroactive steroid 3-alpha-ol-5-beta-pregnan-20-one hemisuccinate, a selective NMDA receptor antagonist improves behavioral performance following spinal cord ischemia. Brain Research 2004, 997:152-158.
18. Leonova J., Thorlin T., Aberg N.D., Eriksson P.S., Ronnback L., Hansson E. Endothelin-1 decreases glutamate uptake in primary cultured rat astrocytes. American Journal of Physiology-Cell Physiology 2001, 281:C1495-C1503.
19. Li Z., Cui S., Zhang Z., Zhou R., Ge Y., Sokabe M., Chen L. DHEA-neuroprotection and -neurotoxicity after transient cerebral ischemia in rats. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 2009, 29:287-296.
20. Li Z., Zhou R., Cui S., Xie G., Cai W., Sokabe M., Chen L. Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor. Neuropharmacology 2006, 51:958-966.
21. Lima-Ojeda J.M., Vogt M.A., Pfeiffer N., Dormann C., Kohr G., Sprengel R., Gass P., Inta D. Pharmacological blockade of GluN2B-containing NMDA receptors induces antidepressant-like effects lacking psychotomimetic action and neurotoxicity in the perinatal and adult rodent brain. Progress in Neuro-Psychopharmacology & Biological Psychiatry 2013, 45:28-33.
22. Lin B., Dietrich W.D., Ginsberg M.D., Globus M.Y., Busto R. MK-801 (dizocilpine) protects the brain from repeated normothermic global ischemic insults in the rat. Journal of Cerebral Blood Flow and Metabolism: Official Journal of the International Society of Cerebral Blood Flow and Metabolism 1993, 13:925-932.
23. Lynch J.K., Nelson K.B. Epidemiology of perinatal stroke. Current Opinion in Pediatrics 2001, 13:499-505.
24. Mateffyova A., Otahal J., Tsenov G., Mares P., Kubova H. Intrahippocampal injection of endothelin-1 in immature rats results in neuronal death, development of epilepsy and behavioral abnormalities later in life. European Journal of Neuroscience 2006, 24:351-360.
25. McAuley M.A. Rodent models of focal ischemia. Cerebrovascular and Brain Metabolism Reviews 1995, 7:153-180.
26. Melcangi R.C., Panzica G., Garcia-Segura L.M. Neuroactive steroids: focus on human brain. Neuroscience 2011, 191:1-5.
27. Mellon S.H. Neurosteroid regulation of central nervous system development. Pharmacology & Therapeutics 2007, 116:107-124.
28. Moyanova S.G., Kortenska L.V., Mitreva R.G., Pashova V.D., Ngomba R.T., Nicoletti F. Multimodal assessment of neuroprotection applied to the use of MK-801 in the endothelin-1 model of transient focal brain ischemia. Brain Research 2007, 1153:58-67.
29. Parsons C.G. NMDA receptors as targets for drug action in neuropathic pain. European Journal of Pharmacology 2001, 429:71-78.
30. Paxinos G., Watson C., Pennisi M., Topple A. Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. Journal of Neuroscience Methods 1985, 13:139-143.
31. Petrovic M., Sedlacek M., Horak M., Chodounska H., Vyklicky L. 20-oxo-5beta-pregnan-3alpha-yl sulfate is a use-dependent NMDA receptor inhibitor. Journal of Neuroscience: Official Journal of the Society for Neuroscience 2005, 25:8439-8450.
32. Rambousek L., Bubenikova-Valesova V., Kacer P., Syslova K., Kenney J., Holubova K., Najmanova V., Zach P., Svoboda J., Stuchlik A., Chodounska H., Kapras V., Adamusova E., Borovska J., Vyklicky L., Vales K. Cellular and behavioural effects of a new steroidal inhibitor of the N-methyl-d-aspartate receptor 3alpha5beta-pregnanolone glutamate. Neuropharmacology 2011, 61:61-68.
33. Scallet A.C., Schmued L.C., Slikker W., Grunberg N., Faustino P.J., Davis H., Lester D., Pine P.S., Sistare F., Hanig J.P. Developmental neurotoxicity of ketamine: morphometric confirmation, exposure parameters, and multiple fluorescent labeling of apoptotic neurons. Toxicological sciences: An Official Journal of the Society of Toxicology 2004, 81:364-370.
34. Schaller B.J. The role of endothelin in stroke: experimental data and underlying pathophysiology. Archives of Medical Science 2006, 2:146-158.
35. Schmued L.C., Albertson C., Slikker W. Fluoro-Jade: a novel fluorochrome for the sensitive and reliable histochemical localization of neuronal degeneration. Brain Research 1997, 751:37-46.
36. Traynelis S.F., Wollmuth L.P., McBain C.J., Menniti F.S., Vance K.M., Ogden K.K., Hansen K.B., Yuan H., Myers S.J., Dingledine R. Glutamate receptor ion channels: structure, regulation, and function. Pharmacological Reviews 2010, 62:405-496.
37. Tsenov G., Mateffyova A., Mares P., Otahal J., Kubova H. Intrahippocampal injection of endothelin-1: a new model of ischemia-induced seizures in immature rats. Epilepsia 2007, 48(Suppl 5):7-13.